Ankit Naik

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• GSK‐J4: An H3K27 histone demethylase inhibitor, as a potential anti‐cancer agent
  International Journal of Cancer 2023 DOI: 10.1002/ijc.34559
  +Save
• Comparative analysis of the occupancy of Histone H3 Lysine 4 methylation in the cells treated with TGFβ and Interferonγ
  Gene 2023 DOI: 10.1016/j.gene.2023.147601
  +Save
• Combination Treatment of a Phytochemical and a Histone Demethylase Inhibitor—A Novel Approach towards Targeting TGFβ-Induced EMT, Invasion, and Migration in Prostate Cancer
  International Journal of Molecular Sciences 2023 DOI: 10.3390/ijms24031860
  +Save
• TGF-β at the crossroads of multiple prognosis in breast cancer, and beyond
  Life Sciences 2022 DOI: 10.1016/j.lfs.2022.121011
  +Save
• Hesperetin modulates TGFβ induced metastatic potential of prostate cancer cells by altering histone methylation marks
  Advances in Cancer Biology - Metastasis 2022 DOI: 10.1016/j.adcanc.2022.100077
  +Save
• Global Gene Expression Regulation Mediated by TGFβ Through H3K9me3 Mark
  Cancer Informatics 2022 DOI: 10.1177/11769351221115135
  +Save
• Global Histone H3 Lysine 4 Trimethylation (H3K4me3) Landscape Changes in Response to TGFβ
  Epigenetics Insights 2021 DOI: 10.1177/25168657211051755
  +Save